Literature DB >> 3305621

Evaluation of biochemical validation measures in determination of smoking status.

G K Stookey, B P Katz, B L Olson, C A Drook, S J Cohen.   

Abstract

This study was designed to evaluate the use of salivary cotinine, salivary thiocyanate, and expired-air carbon monoxide as biochemical validation measures for assessing the smoking status of adults. The participants were 20 known non-smokers plus 216 admitted smokers and 102 proclaimed quitters participating in a clinical trial of approaches to facilitate smoking cessation. Conventional analytical procedures were utilized. By use of data from known non-smokers and admitted smokers, the sensitivity and specificity of the validation measures were as follows: salivary cotinine, 99% and 100%; expired-air carbon monoxide, 96% and 100%; and salivary thiocyanate, 67% and 95%, respectively. The salivary cotinine and expired-air carbon monoxide tests confirmed smoking cessation for 55% and 74%, respectively, of the proclaimed quitters. The length of time since quitting was significantly related to the results observed with the latter measures. Consideration of these observations along with various practical factors suggests that expired-air carbon monoxide assays may be the validation measure of choice for most clinical trials.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3305621     DOI: 10.1177/00220345870660101801

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  20 in total

1.  Misclassification of smoking status in the CARDIA study: a comparison of self-report with serum cotinine levels.

Authors:  L E Wagenknecht; G L Burke; L L Perkins; N J Haley; G D Friedman
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

2.  Brief supportive telephone outreach as a recruitment and intervention strategy for smoking cessation.

Authors:  H A Lando; W L Hellerstedt; P L Pirie; P G McGovern
Journal:  Am J Public Health       Date:  1992-01       Impact factor: 9.308

3.  Smokeless tobacco abstinence effects and nicotine gum dose.

Authors:  D Hatsukami; D Anton; R Keenan; A Callies
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

4.  Telephone support as an adjunct to transdermal nicotine in smoking cessation.

Authors:  H A Lando; S Rolnick; D Klevan; J Roski; L Cherney; G Lauger
Journal:  Am J Public Health       Date:  1997-10       Impact factor: 9.308

5.  Overreporting of smokeless tobacco use by adolescent males.

Authors:  S J Cohen; B P Katz; C A Drook; A G Christen; J L McDonald; B L Olson; L A Cloys; G K Stookey
Journal:  J Behav Med       Date:  1988-08

6.  Topiramate for smoking cessation: a randomized, placebo-controlled pilot study.

Authors:  Cheryl Oncken; Albert J Arias; Richard Feinn; Mark Litt; Jonathan Covault; Mehmet Sofuoglu; Henry R Kranzler
Journal:  Nicotine Tob Res       Date:  2013-09-21       Impact factor: 4.244

7.  The validity of self-reported smoking: a review and meta-analysis.

Authors:  D L Patrick; A Cheadle; D C Thompson; P Diehr; T Koepsell; S Kinne
Journal:  Am J Public Health       Date:  1994-07       Impact factor: 9.308

8.  Serum thiocyanate concentration as an indicator of smoking in relation to deaths from cancer.

Authors:  H Wang; M Sekine; H Yokokawa; S Hamanishi; M Sayama; Y Naruse; H Nakagawa; S Kagamimori
Journal:  Environ Health Prev Med       Date:  2001-07       Impact factor: 3.674

9.  The impact of tetrahydrobiopterin administration on endothelial function before and after smoking cessation in chronic smokers.

Authors:  Beth A Taylor; Amanda L Zaleski; Ellen A Dornelas; Paul D Thompson
Journal:  Hypertens Res       Date:  2015-11-26       Impact factor: 3.872

10.  Effects of varenicline, nicotine or placebo on depressive symptoms in postmenopausal smokers.

Authors:  Naomi Avery; Anne M Kenny; Alison Kleppinger; Jennifer Brindisi; Mark D Litt; Cheryl A Oncken
Journal:  Am J Addict       Date:  2014-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.